Skip Nav Destination
Issues
15 June 2013
-
Cover Image
Cover Image
The cover shows a section of a lymph node biopsy from a patient with chronic lymphocytic leukemia. Immunohistochemical staining shows strong phospho-eIF4E expression within a proliferation center suggesting induction of cap complex formation and protein synthesis within this microenvironment. For details, see the article by Willimott and colleagues on page 3212 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Molecular Pathways
Human Cancer Biology
microRNA Expression Profiles Identify Subtypes of Mantle Cell Lymphoma with Different Clinicobiological Characteristics
Alba Navarro; Guillem Clot; Miriam Prieto; Cristina Royo; Maria Carmela Vegliante; Virginia Amador; Elena Hartmann; Itziar Salaverria; Sílvia Beà; Jose Ignacio Martín-Subero; Andreas Rosenwald; German Ott; Adrian Wiestner; Wyndham H. Wilson; Elías Campo; Luis Hernández
Biological and Clinical Relevance of miRNA Expression Signatures in Primary Plasma Cell Leukemia
Marta Lionetti; Pellegrino Musto; Maria Teresa Di Martino; Sonia Fabris; Luca Agnelli; Katia Todoerti; Giacomo Tuana; Laura Mosca; Maria E. Gallo Cantafio; Vitina Grieco; Gabriella Bianchino; Fiorella D'Auria; Teodora Statuto; Carmela Mazzoccoli; Luciana De Luca; Maria Teresa Petrucci; Massimo Offidani; Francesco Di Raimondo; Antonietta Falcone; Tommaso Caravita; Paola Omede'; Fortunato Morabito; Pierfrancesco Tassone; Mario Boccadoro; Antonio Palumbo; Antonino Neri
Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas
Klaus G. Griewank; Henrike Westekemper; Rajmohan Murali; Monika Mach; Bastian Schilling; Thomas Wiesner; Tobias Schimming; Elisabeth Livingstone; Antje Sucker; Florian Grabellus; Claudia Metz; Daniela Süsskind; Uwe Hillen; Michael R. Speicher; Scott E. Woodman; Klaus-Peter Steuhl; Dirk Schadendorf
Cancer Therapy: Preclinical
ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
Laura Biddlestone-Thorpe; Muhammad Sajjad; Elizabeth Rosenberg; Jason M. Beckta; Nicholas C.K. Valerie; Mary Tokarz; Bret R. Adams; Alison F. Wagner; Ashraf Khalil; Donna Gilfor; Sarah E. Golding; Sumitra Deb; David G. Temesi; Alan Lau; Mark J. O'Connor; Kevin S. Choe; Luis F. Parada; Sang Kyun Lim; Nitai D. Mukhopadhyay; Kristoffer Valerie
Frequent Inactivation of Cysteine Dioxygenase Type 1 Contributes to Survival of Breast Cancer Cells and Resistance to Anthracyclines
Jana Jeschke; Heather M. O'Hagan; Wei Zhang; Rajita Vatapalli; Marilia Freitas Calmon; Ludmila Danilova; Claudia Nelkenbrecher; Leander Van Neste; Ingrid T.G.W. Bijsmans; Manon Van Engeland; Edward Gabrielson; Kornel E. Schuebel; Andreas Winterpacht; Stephen B. Baylin; James G. Herman; Nita Ahuja
Monoclonal Antibody against the Ectodomain of E-Cadherin (DECMA-1) Suppresses Breast Carcinogenesis: Involvement of the HER/PI3K/Akt/mTOR and IAP Pathways
Sabine M. Brouxhon; Stephanos Kyrkanides; Xiaofei Teng; Veena Raja; M. Kerry O'Banion; Robert Clarke; Stephen Byers; Andrew Silberfeld; Carmen Tornos; Li Ma
Imaging, Diagnosis, Prognosis
Transcriptional Characterization of a Prospective Series of Primary Plasma Cell Leukemia Revealed Signatures Associated with Tumor Progression and Poorer Outcome
Katia Todoerti; Luca Agnelli; Sonia Fabris; Marta Lionetti; Giacomo Tuana; Laura Mosca; Luigia Lombardi; Vitina Grieco; Gabriella Bianchino; Fiorella D'Auria; Teodora Statuto; Carmela Mazzoccoli; Luciana De Luca; Maria Teresa Petrucci; Fortunato Morabito; Massimo Offidani; Francesco Di Raimondo; Antonietta Falcone; Paola Omede'; Pierfrancesco Tassone; Mario Boccadoro; Antonio Palumbo; Antonino Neri; Pellegrino Musto
Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
A. Ari Hakimi; Irina Ostrovnaya; Boris Reva; Nikolaus Schultz; Ying-Bei Chen; Mithat Gonen; Han Liu; Shugaku Takeda; Martin H. Voss; Satish K. Tickoo; Victor E. Reuter; Paul Russo; Emily H. Cheng; Chris Sander; Robert J. Motzer; James J. Hsieh; for The ccRCC Cancer Genome Atlas (KIRC TCGA) Research Network investigators
EDNRB and DCC Salivary Rinse Hypermethylation Has a Similar Performance as Expert Clinical Examination in Discrimination of Oral Cancer/Dysplasia versus Benign Lesions
Juliana Schussel; Xian Chong Zhou; Zhe Zhang; Kavita Pattani; Francisco Bermudez; Germain Jean-Charles; Thomas McCaffrey; Tapan Padhya; Joan Phelan; Silvia Spivakovsky; Mariana Brait; Ryan Li; Helen Yoo Bowne; Judith D. Goldberg; Linda Rolnitzky; Miriam Robbins; A. Ross Kerr; David Sirois; Joseph A. Califano
PIK3CA and PTEN Gene and Exon Mutation-Specific Clinicopathologic and Molecular Associations in Colorectal Cancer
Fiona L. Day; Robert N. Jorissen; Lara Lipton; Dmitri Mouradov; Anuratha Sakthianandeswaren; Michael Christie; Shan Li; Cary Tsui; Jeannie Tie; Jayesh Desai; Zheng-Zhou Xu; Peter Molloy; Vicki Whitehall; Barbara A. Leggett; Ian T. Jones; Stephen McLaughlin; Robyn L. Ward; Nicholas J. Hawkins; Andrew R. Ruszkiewicz; James Moore; Dana Busam; Qi Zhao; Robert L. Strausberg; Peter Gibbs; Oliver M. Sieber
Cancer Therapy: Clinical
Prospective Phase II Study on 5-Days Azacitidine for Treatment of Symptomatic and/or Erythropoietin Unresponsive Patients with Low/INT-1–Risk Myelodysplastic Syndromes
Carla Filì; Michele Malagola; Matilde Y. Follo; Carlo Finelli; Ilaria Iacobucci; Giovanni Martinelli; Federica Cattina; Cristina Clissa; Anna Candoni; Renato Fanin; Marco Gobbi; Monica Bocchia; Marzia Defina; Pierangelo Spedini; Cristina Skert; Lucia Manzoli; Lucio Cocco; Domenico Russo
Predictive Biomarkers and Personalized Medicine
CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity
Anne-Joy M. de Graan; Laure Elens; Jason A. Sprowl; Alex Sparreboom; Lena E. Friberg; Bronno van der Holt; Pleun J. de Raaf; Peter de Bruijn; Frederike K. Engels; Ferry A.L.M. Eskens; Erik A.C. Wiemer; Jaap Verweij; Ron H.J. Mathijssen; Ron H.N. van Schaik
Letters to the Editor
Retraction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds